• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4602291)   Today's Articles (5060)   Subscriber (49368)
For: Shimazaki C, Atzpodien J, Wisniewski D, Gulati SC, Kolitz JE, Fried J, Clarkson BD. Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cells. Acta Haematol 1988;80:203-9. [PMID: 3146198 DOI: 10.1159/000205638] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Number Cited by Other Article(s)
1
Godfrey J, Benson DM. The role of natural killer cells in immunity against multiple myeloma. Leuk Lymphoma 2012;53:1666-76. [PMID: 22423650 DOI: 10.3109/10428194.2012.676175] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
2
Fionda C, Soriani A, Malgarini G, Iannitto ML, Santoni A, Cippitelli M. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation. THE JOURNAL OF IMMUNOLOGY 2009;183:4385-94. [PMID: 19748980 DOI: 10.4049/jimmunol.0901797] [Citation(s) in RCA: 71] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
3
Gulati SC, Shimazaki C, Lemoli RM, Atzpodien J, Clarkson BD. Ex vivo treatment of myeloma cells by 4-HC, VP-16, LAK cells and antibodies. Eur J Haematol Suppl 2009;51:164-72. [PMID: 2627987 DOI: 10.1111/j.1600-0609.1989.tb01511.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
4
Carlsten M, Malmberg KJ, Ljunggren HG. Natural killer cell-mediated lysis of freshly isolated human tumor cells. Int J Cancer 2009;124:757-62. [DOI: 10.1002/ijc.24082] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
5
Frohn C, Höppner M, Schlenke P, Kirchner H, Koritke P, Luhm J. Anti-myeloma activity of natural killer lymphocytes. Br J Haematol 2002;119:660-4. [PMID: 12437641 DOI: 10.1046/j.1365-2141.2002.03879.x] [Citation(s) in RCA: 90] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
6
Munshi NC. Immunoregulatory mechanisms in multiple myeloma. Hematol Oncol Clin North Am 1997;11:51-69. [PMID: 9081204 DOI: 10.1016/s0889-8588(05)70415-9] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
7
San Miguel JF, Garcia-Sanz R, Gonzalez M, Orfao A. Immunophenotype and DNA cell content in multiple myeloma. BAILLIERE'S CLINICAL HAEMATOLOGY 1995;8:735-59. [PMID: 8845570 DOI: 10.1016/s0950-3536(05)80257-4] [Citation(s) in RCA: 49] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
8
Peest D, Leo R, Bloche S, Hein R, Stannat-Kiessling S, Tschechne B, Fett W, Harms P, Hoffmann L, Bartl R. Low-dose recombinant interleukin-2 therapy in advanced multiple myeloma. Br J Haematol 1995;89:328-37. [PMID: 7873383 DOI: 10.1111/j.1365-2141.1995.tb03308.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
9
Immunoregulation of Murine and Human Myeloma. Hematol Oncol Clin North Am 1992. [DOI: 10.1016/s0889-8588(18)30353-8] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
10
Cimino G, Avvisati G, Amadori S, Cava MC, Giannarelli D, Di Nucci GD, Magliocca V, Petrucci MT, Poti G, Sgadari C. High serum IL-2 levels are predictive of prolonged survival in multiple myeloma. Br J Haematol 1990;75:373-7. [PMID: 2386771 DOI: 10.1111/j.1365-2141.1990.tb04351.x] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
11
Atzpodien J, Kirchner H. Cancer, cytokines, and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms. KLINISCHE WOCHENSCHRIFT 1990;68:1-11. [PMID: 2407894 DOI: 10.1007/bf01648882] [Citation(s) in RCA: 54] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
12
Gottlieb DJ, Brenner MK, Heslop HE, Bianchi AC, Bello-Fernandez C, Mehta AB, Newland AC, Galazka AR, Scott EM, Hoffbrand AV. A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease. Br J Cancer 1989;60:610-5. [PMID: 2803933 PMCID: PMC2247111 DOI: 10.1038/bjc.1989.324] [Citation(s) in RCA: 63] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]  Open
13
Peest D, de Vries I, Hölscher R, Leo R, Deicher H. Effect of interleukin-2 on the ex vivo growth of human myeloma cells. Cancer Immunol Immunother 1989;30:227-32. [PMID: 2532059 PMCID: PMC11038810 DOI: 10.1007/bf01665009] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/1989] [Accepted: 07/18/1989] [Indexed: 01/01/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA